Is this you? Create Your Porfile
Avatar

Martin Szelagiewicz

Novartis

Hotspot
Bubble
Bubble
[Coming Soon]
 Word Cloud
Cloud
 Mosaic Glass
Mosaic
[Coming Soon]

Archive | 2001

Crystalline forms of atorvastatin

Paul Adriaan Van Der Schaaf; Fritz Blatter; Martin Szelagiewicz; Kai-Uwe Schöning

Archive | 2003

Crystalline form F of Atorvastatin hemi-calcium salt

Fritz Blatter; Martin Szelagiewicz; Der Schaaf Paul Adriaan Van

Archive | 2001

Crystalline forms of venlafaxine hydrochloride

Paul Adriaan Van Der Schaaf; Claudia Marcolli; Martin Szelagiewicz; Beat Freiermuth

Archive | 1998

Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic

Robert Portmann; Urs Christoph Hofmeier; Andreas Burkhard; Walter Scherrer; Martin Szelagiewicz

Archive | 2004

Crystalline forms of pitavastatin calcium

Paul Adriaan Van Der Schaaf; Fritz Blatter; Martin Szelagiewicz; Kai-Uwe Schoening

Archive | 2006

Approaches to Polymorphism Screening

Rolf Hilfiker; Susan M. De Paul; Martin Szelagiewicz

Archive | 2006

Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Robert Portmann; Urs Christoph Hofmeier; Andreas Burkhard; Walter Scherrer; Martin Szelagiewicz

Archive | 2002

Sealing system with flow channels

Fritz Blatter; Brigitte Cron-Eckhardt; Urs Christoph Hofmeier; Peter Koller; Claudia Marcolli; Martin Szelagiewicz

Archive | 2001

Crystalline forms of cerivastatin sodium

Paul Adriaan Van Der Schaaf; Fritz Blatter; Martin Szelagiewicz; Nicole End

Archive | 2013

Multicomponent crystals comprising dasatinib and selected co-crystal formers

Tiziana Chiodo; Andreas Hafner; Tobias Hintermann; Beate Salvador; Martin Szelagiewicz; Fritz Blatter; Bernd Siebenhaar; Marcus Vossen

Explore More
Researchain Logo
Decentralizing Knowledge